cagrilintide fda 5mg cagrilintide

What is the difference between cagrilintide and CagriSema

We use the Charles River Endosafe PTS system to test for bacterial endotoxins following USP guidelines: The following are suitability parameters that verify the system was working properly and the sample prep dilution is appropriate for accurate results

Tirzepatide is FDA-approved as Mounjaro for type 2 diabetes (2022) and as Zepbound for chronic weight management (2023) and for moderate-to-severe obstructive sleep apnea (2024), and it is EMA-approved as well

Both are dominated by gastrointestinal adverse events nausea, constipation, diarrhea, vomiting that are mostly mild-to-moderate and dose-related